oral combination of hmas venetoclax in unfit or elderly patients with aml
Published 2 years ago • 186 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
1:50
the challenge of treating elderly patients with aml with venetoclax plus azacitidine
-
3:25
treatment approaches for elderly/unfit patients with aml ineligible for intensive chemotherapy
-
1:38
managing aml in elderly patients
-
1:12
hma in combination with venetoclax and magrolimab in the treatment of aml
-
3:14
standard treatment of elderly patients with aml & evaluating idh inhibitors in younger patients
-
2:32
how quickly does aml progress? #aml
-
6:01
runyes 8/12l autoclave tutorial
-
6:13
how has acute myeloid leukemia treatment for elderly people changed in 2021?
-
2:21
infectious complications & outcomes of patients with aml receiving treatment with hmas ± venetoclax
-
1:51
rationale of omniverse: oral azacitidine venetoclax in patients with r/r or newly diagnosed aml
-
0:45
adapting aml treatment for elderly patients
-
1:32
is venetoclax in combination with low-dose cytarabine a safe regimen for the treatment of aml?
-
2:45
the addition of venetoclax to hmas for the treatment of cmml: a retrospective psm analysis
-
5:35
venetoclax plus hmas in idh-mutant aml
-
3:35
safety and efficacy of venetoclax-based regimens for aml
-
3:03
cpx-351 vs. hma plus venetoclax in the treatment of patients with aml
-
1:50
treating patients with poor-risk cytogenetics with venetoclax and hmas
-
2:37
maintenance venetoclax and 5-azacytidine in patients with aml
-
2:46
combination approaches in aml and overcoming venetoclax resistance
-
2:11
cpx-351 plus venetoclax in patients with newly-diagnosed high-risk aml
-
1:46
the challenges facing elderly aml treatment